IchikawaYSatoTOhsawaI, et al.Preventable in-body hydrogen explosions from high-concentration H2 inhalers in Japan — Switch to safe, low-concentration hydrogen therapy. Int J Risk Saf Med2026; 37(1): 90. https://doi.org/10.1177/09246479251414573[Epub ahead of print].
2.
LausGBertozziGDi FazioA, et al.Proactive risk analysis in chemotherapy nursing processes: a systematic review of FMEA/FMECA applications. Int J Risk Saf Med2026; 37(1): 1. https://doi.org/10.1177/09246479261432846[Epub ahead of print].
3.
RhodesP.Medical science and the madness of crowds; context for our COVID pandemic years. Int J Risk Saf Med2026; 37(1): 11-22. https://doi.org/10.1177/09246479261456462[Epub ahead of print].
4.
OkoroEOIkobaNAOkoroBE, et al.Paradoxical increase in global COVID-19 deaths with vaccination coverage: World Health Organization estimates (2020–2023). Int J Risk Saf Med2025; 36(4): 313. https://doi.org/10.1177/09246479251336610
OkoroEOIkobaNAOkoroBE, et al.Reply to comment on “Population-Level COVID-19 mortality trends”. Int J Risk Saf Med2025; 36(4): 314–316. https://doi.org/10.1177/09246479251362606
7.
MannicheVFürstTSchmelingM, et al.Rates of successful conceptions according to COVID-19 vaccination status: data from the Czech Republic. Int J Risk Saf Med2025; 36(4): 302–306. https://doi.org/10.1177/09246479251353384
8.
SudaC. Comment on “Rates of successful conceptions according to COVID-19 vaccination status: data from the Czech Republic”. Int J Risk Saf Med2026; 37(1): 152–153. https://doi.org/10.1177/09246479251377034
9.
MannicheVFürstTSchmelingM, et al.Author’s response: rates of successful conceptions according to COVID-19 vaccination status: data from the Czech Republic. Int J Risk Saf Med2026; 37(1): 154. https://doi.org/10.1177/09246479251378936
10.
LatasterR.The causes of Australian excess deaths in 2021, and beyond: an ecological study considering COVID-19, the lockdowns, and the vaccines. Int J Risk Saf Med2026; 37(1): 11-28. https://doi.org/10.1177/09246479261426743[Epub ahead of print].
11.
LexchinJ.Risk management plans and drug safety in Canada: a cross-sectional study. Int J Risk Saf Med2025; 36(4): 185-192. [Epub ahead of print].
